- Drug Class
- Tricyclic Antidepressant (TCA)
- Mechanism of Action (MOA)
- Inhibits serotonin and norepinephrine reuptake; also blocks muscarinic, H1, and α1 receptors.
- Black Box Warning
- Increased suicidality in patients <25.
- Clinical Notes
- Labeled for depression; used off-label for neuropathic pain, migraine prophylaxis, insomnia (sedative). Lethal in overdose (QRS widening, arrhythmia → sodium bicarbonate).
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology